U

University of Massachusetts Chan Medical School | Medicine Department - Rheumatology Division

Research site
(Unclaimed)
Location
55 Lake Avenue North, Worcester, Massachusetts, United States of America

Site insights

Top conditions

Top treatments

Pembrolizumab
Ustekinumab
NS-018
Fluticasone Propionate
CC-97540
Ritonavir
Betamethasone Valerate
Deucravacitinib
Platinum
Luveltamab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

13 of 22 total trials

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents with Nonsegmental Vitiligo (Active and Stable) Tranquillo

Enrolling
Stable Nonsegmental Vitiligo
Active Nonsegmental Vitiligo
Drug: Ritlecitinib
Drug: Placebo

This is an open label Phase 1b/2 study to evaluate the efficacy and safety of ACR-368 as monotherapy or in combination with ultralow dose gemcitabine...

Enrolling
Endometrial Adenocarcinoma
Urothelial Carcinoma
Drug: ACR-368
Diagnostic Test: OncoSignature
Locations recently updated

The purpose of this study is to establish the tolerability, preliminary efficacy, and pharmacokinetics of CC-97540 in participants with severe, refra...

Enrolling
Systemic Sclerosis
Idiopathic Inflammatory Myopathy
Drug: Fludarabine
Drug: CC-97540

The purpose of this study is to evaluate the effect of moderate or severe liver impairment on the drug levels of oral azacitidine and the safety and...

Enrolling
Neoplasms
Hepatic Insufficiency
Drug: Onureg

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe System...

Enrolling
Systemic Lupus Erythematosus
Drug: Deucravacitinib
Other: Placebo

The purpose of this study is to learn about the safety and effects of sisunatovir. Sisunatovir is studied for the possible treatment of Respiratory S...

Enrolling
Respiratory Syncytial Virus Infection
Drug: Sisunatovir
Drug: Placebo

The main purpose of this clinical study is to evaluate a 6-valent OspA-based Lyme disease vaccine (VLA15) for prevention of Lyme disease within North...

Active, not recruiting
Lyme Disease
Biological: VLA15
Other: Saline

The purpose of this clinical trial is to learn about the safety, pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and e...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

This study is designed to assess the safety and efficacy of lenvatinib in combination with pembrolizumab versus standard of care (SOC) chemotherapy,...

Enrolling
Squamous Cell Carcinoma of Head and Neck
Drug: Cetuximab
Drug: Capecitabine

A Phase 2/3 study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer (including fal...

Enrolling
Primary Peritoneal Cancer
Epithelial Ovarian Cancer
Drug: Luveltamab tazevibulin
Drug: Pegfilgrastim

AOC 1044-CS1 (EXPLORE44) is a Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamic effects of single and multi...

Enrolling
Exon 44
Duchenne Muscular Dystrophy
Drug: Placebo
Drug: AOC 1044

This study is to evaluate the safety and efficacy of pembrolizumab/vibostolimab (MK-7684A) in combination with concurrent chemoradiotherapy (cCRT) fo...

Enrolling
Carcinoma, Non-Small-Cell Lung
Drug: carboplatin
Drug: etoposide

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Enrolling
Lower Respiratory Tract Illness
Biological: Placebo
Biological: RSVpreF

Trial sponsors

Pfizer logo
Bristol-Myers Squibb (BMS) logo
Merck Sharp & Dohme (MSD) logo
U
A
A
Dartmouth Health logo
J
N
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems